Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PH1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07057349
What this trial is testing

CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer

Who this might be right for
Metastatic CancerUnresectable Solid Tumor
Cytosite Biopharma Inc. 40
Testing effectiveness (Phase 2)Study completedNCT02706886
What this trial is testing

Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1

Who this might be right for
Primary Hyperoxaluria Type 1 (PH1)
Alnylam Pharmaceuticals 52
Large-scale testing (Phase 3)Ended earlyNCT03371173
What this trial is testing

ORal IrON Supplementation With Ferric Maltol in Patients With Pulmonary Hypertension (ORION-PH-1)

Who this might be right for
Hypertension, PulmonaryAnemia, Iron Deficiency
Hannover Medical School 22
Early research (Phase 1)Study completedNCT03574142
What this trial is testing

A Ph 1 Study of Epanova® in Healthy Chineses

Who this might be right for
Healthy Subjects
AstraZeneca 14
Not applicableLooking for participantsNCT02026388
What this trial is testing

Rare Kidney Stone Consortium Biobank

Who this might be right for
Primary HyperoxaluriaDent DiseaseAPRT Deficiency+1 more
Mayo Clinic 2,000
Early research (Phase 1)Looking for participantsNCT07776626
What this trial is testing

Phase I Exploratory Study of YOLT-203 in Patients With Primary Hyperoxaluria Type 1 (PH1)

Who this might be right for
Primary Hyperoxaluria Type 1PH1
YolTech Therapeutics Co., Ltd 9
Early research (Phase 1)Study completedNCT01948843
What this trial is testing

Ph 1 ADI-PEG 20 Plus Doxorubicin; Patients With HER2 Negative Metastatic Breast Cancer

Who this might be right for
HER2 Negative Metastatic Breast Cancer
Polaris Group 15
Not applicableLooking for participantsNCT00588562
What this trial is testing

Rare Kidney Stone Consortium Patient Registry

Who this might be right for
Primary HyperoxaluriaDent DiseaseCystinuria+1 more
Mayo Clinic 730
Testing effectiveness (Phase 2)Study completedNCT03504488
What this trial is testing

CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)

Who this might be right for
Non Small Cell Lung CancerTriple Negative Breast CancerMelanoma+1 more
BioAtla, Inc. 132
Early research (Phase 1)Ended earlyNCT02029690
What this trial is testing

Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin

Who this might be right for
Pleural Mesothelioma Malignant AdvancedPeritoneal Mesothelioma Malignant AdvancedNon-squamous Non-small Cell Lung Carcinoma+4 more
Polaris Group 85
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07579221
What this trial is testing

Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)WithdrawnNCT02923986
What this trial is testing

Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With Dasatinib in Patients With Ph + CML Who Have Failed TKI, Ph+ AML, Ph+ MDS

Who this might be right for
Chronic Myelogenous Leukemia, Ph1-PositiveAcute Myeloid LeukemiaMyelodysplastic Syndrome
Bio-Path Holdings, Inc.
Early research (Phase 1)Ended earlyNCT04589260
What this trial is testing

TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Theravance Biopharma 72
Early research (Phase 1)Study completedNCT00284973
What this trial is testing

Safety and Immunogenicity of a Malaria Vaccine Candidate

Who this might be right for
Prophylaxis Against Plasmodium Falciparum Malaria
Shanghai Wanxing Bio-Pharmaceutical Co. Ltd. 70
Post-approval studies (Phase 4)Study completedNCT06427811
What this trial is testing

Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation

Who this might be right for
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
Novartis Pharmaceuticals 85
Early research (Phase 1)Study completedNCT02209766
What this trial is testing

A Ph1 Study in Healthy Male Japanese and Caucasian After Single and Multiple Doses of D5884(Omega-3-carboxylic Acids)

Who this might be right for
Healthy
AstraZeneca 86
Testing effectiveness (Phase 2)WithdrawnNCT05177276
What this trial is testing

Selinexor Combination Ph 1 Study

Who this might be right for
Solid Tumor Malignancy
Martin Gutierrez
Not applicableStudy completedNCT06283082
What this trial is testing

Oxalate Excretion Profile in Patients With a Heterozygous Mutation of the AGXT (Alanine-glyoxylate Aminotransferase) Gene

Who this might be right for
Hyperoxaluria (Disorder)
Hospices Civils de Lyon 25
Testing effectiveness (Phase 2)Looking for participantsNCT07587021
What this trial is testing

Study of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1 (PH1)

Who this might be right for
Primary Hyperoxaluria Type 1PH1
YolTech Therapeutics Co., Ltd 36
Early research (Phase 1)Study completedNCT02101593
What this trial is testing

Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Polaris Group 8
Next Page